AR019899A1 - Composicion farmaceutica y un procedimiento para prepararla. - Google Patents
Composicion farmaceutica y un procedimiento para prepararla.Info
- Publication number
- AR019899A1 AR019899A1 ARP990103299A ARP990103299A AR019899A1 AR 019899 A1 AR019899 A1 AR 019899A1 AR P990103299 A ARP990103299 A AR P990103299A AR P990103299 A ARP990103299 A AR P990103299A AR 019899 A1 AR019899 A1 AR 019899A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- goitre
- iodine
- lack
- microcrystalline cellulose
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 abstract 6
- 206010018498 Goitre Diseases 0.000 abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 2
- YDTFRJLNMPSCFM-YDALLXLXSA-M levothyroxine sodium anhydrous Chemical compound [Na+].IC1=CC(C[C@H](N)C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 YDTFRJLNMPSCFM-YDALLXLXSA-M 0.000 abstract 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 2
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 2
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 201000003872 goiter Diseases 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960004839 potassium iodide Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002271 resection Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composicion farmacéutica que contiene levotiroxina sodica, yoduro de potasio, celulosa microcristalina y agentes ligantes, y se encuentra libre deantioxidantes u otras sustancias auxiliares. Esta nueva composicion presenta una estabilidad mejorada ypuede ser empleada como preparado combinado de hormonatiroidea en los casos de bocio eutiroideo por falta de yodo y/o de una profilaxis recidiva después de una reseccion de un bocio por falta de yodo, debido a sugran proporcion de yoduro como segundasustancia activa. Un procedimiento para preparar la composicion farmacéutica del invento, en el cual mediante unagranulacion en lecho fluidizado se rocía la levotiroxina sodica y el yoduro de potasio, que se encuentran suspendidos en solucion acuosadehidroxipropilmetilcelulosa y/o gelatina, sobre la celulosa microcristalina, luego se anade un agente dispersante y un lubricante, se mezcla y se comprime lamezcla en forma de tabletas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19830246A DE19830246A1 (de) | 1998-07-07 | 1998-07-07 | Pharmazeutische Zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
AR019899A1 true AR019899A1 (es) | 2002-03-20 |
Family
ID=7873182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103299A AR019899A1 (es) | 1998-07-07 | 1999-07-07 | Composicion farmaceutica y un procedimiento para prepararla. |
Country Status (18)
Country | Link |
---|---|
US (1) | US6491946B1 (es) |
EP (1) | EP1094841B1 (es) |
JP (1) | JP2002520296A (es) |
KR (1) | KR20010071765A (es) |
CN (1) | CN1307486A (es) |
AR (1) | AR019899A1 (es) |
AT (1) | ATE273697T1 (es) |
AU (1) | AU751575B2 (es) |
BR (1) | BR9911884A (es) |
CA (1) | CA2336748A1 (es) |
CZ (1) | CZ296897B6 (es) |
DE (2) | DE19830246A1 (es) |
HU (1) | HUP0104985A3 (es) |
ID (1) | ID27150A (es) |
NO (1) | NO20010089D0 (es) |
PL (1) | PL344834A1 (es) |
SK (1) | SK20042000A3 (es) |
WO (1) | WO2000002586A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19821625C1 (de) * | 1998-05-15 | 2000-01-05 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
JP2004525109A (ja) * | 2001-02-15 | 2004-08-19 | キング・ファーマシューティカルズ・インコーポレイティッド | 安定化された甲状腺ホルモン医薬組成物、及びその製法 |
US20030199585A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G Andrew | Levothyroxine compositions and methods |
US20030194436A1 (en) * | 2001-08-10 | 2003-10-16 | Franz Andrew G. | Immediate release pharmaceutical compositions |
US20030195254A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
US7192657B2 (en) * | 2003-04-15 | 2007-03-20 | 3M Innovative Properties Company | Ethynyl containing electron transport dyes and compositions |
US20060183804A1 (en) * | 2004-12-27 | 2006-08-17 | Brinkman Kyle R | Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions |
US7858663B1 (en) | 2007-10-31 | 2010-12-28 | Pisgah Laboratories, Inc. | Physical and chemical properties of thyroid hormone organic acid addition salts |
US20150017236A1 (en) * | 2013-07-09 | 2015-01-15 | Jefferson J. Gregory | Pharmaceutical compositions of thyroid hormone |
US20200046664A1 (en) | 2016-10-10 | 2020-02-13 | Ftf Pharma Private Limited | Method for preparation of liquid oral composition of l-thyroxin |
DE102017122807B4 (de) | 2017-09-29 | 2023-02-09 | Berlin-Chemie Ag | Orales Schilddrüsentherapeutikum |
EP3576795B1 (de) | 2017-02-03 | 2021-04-07 | Berlin-Chemie AG | Orales schilddrüsentherapeutikum |
KR20240039868A (ko) * | 2022-09-20 | 2024-03-27 | 한국유나이티드제약 주식회사 | 갑상선 보호용 약학조성물 및 이의 제조방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225204A (en) * | 1991-11-05 | 1993-07-06 | Chen Jivn Ren | Stable dosage of levothyroxine sodium and process of production |
DE19541128C2 (de) * | 1995-10-27 | 1997-11-27 | Henning Berlin Gmbh & Co | Stabilisierte schilddrüsenhormonhaltige Arzneimittel |
US5635209A (en) * | 1995-10-31 | 1997-06-03 | Vintage Pharmaceuticals, Inc. | Stabilized composition of levothyroxine sodium medication and method for its production |
US5955105A (en) * | 1995-11-14 | 1999-09-21 | Knoll Pharmaceutical Company | Stabilized thyroid hormone preparations and methods of making same |
HUT75956A (en) * | 1995-11-29 | 1997-05-28 | Cyclolab | Pharmaceutical composition containing thyroxine |
-
1998
- 1998-07-07 DE DE19830246A patent/DE19830246A1/de not_active Withdrawn
-
1999
- 1999-06-29 PL PL99344834A patent/PL344834A1/xx unknown
- 1999-06-29 AT AT99931209T patent/ATE273697T1/de active
- 1999-06-29 WO PCT/EP1999/004485 patent/WO2000002586A1/de active IP Right Grant
- 1999-06-29 US US09/743,114 patent/US6491946B1/en not_active Expired - Fee Related
- 1999-06-29 JP JP2000558845A patent/JP2002520296A/ja active Pending
- 1999-06-29 BR BR9911884-0A patent/BR9911884A/pt not_active IP Right Cessation
- 1999-06-29 EP EP99931209A patent/EP1094841B1/de not_active Expired - Lifetime
- 1999-06-29 CA CA002336748A patent/CA2336748A1/en not_active Abandoned
- 1999-06-29 KR KR1020017000222A patent/KR20010071765A/ko not_active Application Discontinuation
- 1999-06-29 CZ CZ20010074A patent/CZ296897B6/cs not_active IP Right Cessation
- 1999-06-29 SK SK2004-2000A patent/SK20042000A3/sk unknown
- 1999-06-29 AU AU47793/99A patent/AU751575B2/en not_active Ceased
- 1999-06-29 HU HU0104985A patent/HUP0104985A3/hu unknown
- 1999-06-29 DE DE59910298T patent/DE59910298D1/de not_active Expired - Lifetime
- 1999-06-29 CN CN99808077A patent/CN1307486A/zh active Pending
- 1999-06-29 ID IDW20010180A patent/ID27150A/id unknown
- 1999-07-07 AR ARP990103299A patent/AR019899A1/es not_active Application Discontinuation
-
2001
- 2001-01-05 NO NO20010089A patent/NO20010089D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000002586A1 (de) | 2000-01-20 |
ATE273697T1 (de) | 2004-09-15 |
NO20010089L (no) | 2001-01-05 |
AU751575B2 (en) | 2002-08-22 |
JP2002520296A (ja) | 2002-07-09 |
EP1094841B1 (de) | 2004-08-18 |
CZ200174A3 (en) | 2001-05-16 |
SK20042000A3 (sk) | 2001-09-11 |
HUP0104985A3 (en) | 2003-03-28 |
BR9911884A (pt) | 2001-03-27 |
KR20010071765A (ko) | 2001-07-31 |
ID27150A (id) | 2001-03-08 |
US6491946B1 (en) | 2002-12-10 |
EP1094841A1 (de) | 2001-05-02 |
HUP0104985A2 (hu) | 2002-04-29 |
PL344834A1 (en) | 2001-11-19 |
AU4779399A (en) | 2000-02-01 |
CZ296897B6 (cs) | 2006-07-12 |
DE59910298D1 (de) | 2004-09-23 |
CA2336748A1 (en) | 2000-01-20 |
CN1307486A (zh) | 2001-08-08 |
NO20010089D0 (no) | 2001-01-05 |
DE19830246A1 (de) | 2000-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR019899A1 (es) | Composicion farmaceutica y un procedimiento para prepararla. | |
BR0003158A (pt) | Formulação de dosagem oral de derretimentoinstantâneo | |
ES2165833T1 (es) | Composicion farmaceutica revestida enterica y procedimiento de fabricacion. | |
PE71699A1 (es) | Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra | |
CO5190688A1 (es) | Formas farmaceuticas de administracion oral al menos parcialmente retardadas cuya sustancia activa tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparac | |
PE20001414A1 (es) | Procedimiento de preparacion de globulos que contienen 50% en peso o mas de una sustancia farmaceutica de hidrosolubilidad | |
DE69927963D1 (de) | Gelierbare pharmazeutische zusammensetzungen | |
KR900012606A (ko) | 이중 정제 | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
KR950007841A (ko) | 트라마돌 염을 함유하는 서방성 약물 제제 | |
AR015524A1 (es) | FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO. | |
PT1027037E (pt) | Composicao farmaceutica que compreende clodronato como ingredientes activo e celulose microcristalina silicificada como excipiente | |
AR017512A1 (es) | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas | |
AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
PE20060075A1 (es) | Composiciones farmaceuticas de alisciren | |
BRPI0709847B8 (pt) | composição farmacêutica sólida de liberação rápida contendo paracetamol e carbonato de cálcio | |
RU2010123282A (ru) | Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение | |
AR037260A1 (es) | Formulaciones de proteinas de liberacion sostenida acuosas | |
CL2004000899A1 (es) | Composicion farmaceutica que contiene la sal sodica de telmisartan y un agente diuretico y procedimiento de preparacion. | |
AR054806A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
ITRM20000667A1 (it) | Compressa matrice che permette la liberazione prolungata di trimetazidina dopo somministrazione per via orale. | |
ES2149990T3 (es) | Composiciones farmaceuticas solidas que contienen ingrediente activo de acido (s)-2-(4-isobutilfenil)propionico y celulosa microcristalina y silice coloidal como excipientes. | |
AR010716A1 (es) | Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante | |
GT199900004A (es) | Comprimido de mesilato de trovafloxacino. | |
AR012480A1 (es) | Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |